Global investment in longevity reached $10B in 2021, marking a pivotal year.The global market for longevity is expected to grow from $76.36B in 2024 to $366.58B by 2032.Longevity startups raised over $4.7B in the first half of 2024, with a focus on medicine and advanced therapeutics.Non-biotech startups and FemTech are also emerging as key players in the longevity market.